Chemical Structure and Pharmacodynamics
The pharmacological profile of trimecaine (Trimecainum) is largely determined by its classification as an amide-type local anesthetic. Structurally, this substituted amide demonstrates a high degree of similarity to lidocaine. In medical practice, it is traditionally used in the hydrochloride salt form.
To objectively evaluate the pharmacodynamic properties of the drug, it is typically compared with the standard ester-type anesthetic, procaine. This comparison reveals the following key features:
- Anesthetic potency: The drug demonstrates high efficacy, exceeding the activity of procaine by 2–3 times.
- Duration of effect: Characterized by a longer clinical duration. Analgesia persists for 2 to 4 hours, making it convenient for prolonged procedures.
- Safety profile: The trade-off for high activity is increased toxicity. It is reliably higher than that of procaine, which dictates the need for careful control of the administered dose.
Concentrations and Types of Anesthesia
The success of local anesthesia and patient safety depend directly on the correct choice of solution concentration. Trimecaine demonstrates varying efficacy depending on the route of administration, as reflected in strict dosage regimens.
| Type of Anesthesia | Recommended Solution Concentration |
|---|---|
| Infiltration | 0.125% – 0.5% |
| Nerve block (Conduction) | 1% – 2% |
| Spinal | 5% |
Surface (topical) anesthesia should be considered separately. For this type of pain relief, the drug is recognized as having low efficacy. To achieve even a minimal therapeutic effect on mucous membranes, very high solution concentrations—from 2% to 5%—are required. However, even at these levels, it is significantly inferior to other, more specialized local anesthetics.
Resorptive Effects and Precautions
In addition to its local action, upon absorption into the systemic circulation, the drug exerts a noticeable resorptive effect primarily directed at the central nervous system (CNS). The nature of this effect is strictly dose-dependent:
- At therapeutic doses, an inhibitory effect on the CNS predominates. Clinically, this manifests as noticeable sedative and hypnotic effects.
- During intoxication (due to an excessive dose or accidental intravascular injection), the response profile changes dramatically. There is a critical risk of developing severe neurological reactions, particularly clonic seizures.
To minimize systemic absorption and prevent toxicity, special pharmacological precautions are applied. Standard practice involves adding epinephrine to the anesthetic solution. This achieves two goals simultaneously: significantly reducing the overall systemic toxicity of the drug and further prolonging its local anesthetic effect.